| Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles’ heel for the TB-causing pathogen A Maitra, T Munshi, J Healy, LT Martin, W Vollmer, NH Keep, S Bhakta FEMS microbiology reviews 43 (5), 548-575, 2019 | 201 | 2019 |
| Repurposing—a ray of hope in tackling extensively drug resistance in tuberculosis A Maitra, S Bates, T Kolvekar, PV Devarajan, JD Guzman, S Bhakta International Journal of Infectious Diseases 32, 50-55, 2015 | 87 | 2015 |
| Repurposing drugs for treatment of tuberculosis: a role for non-steroidal anti-inflammatory drugs A Maitra, S Bates, M Shaik, D Evangelopoulos, I Abubakar, TD McHugh, ... British medical bulletin 118 (1), 138, 2016 | 65 | 2016 |
| Design and Synthesis of 1-((1,5-Bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl)methyl)-4-methylpiperazine (BM212) and N-Adamantan-2-yl-N′-((E)-3,7 … S Bhakta, N Scalacci, A Maitra, AK Brown, S Dasugari, D Evangelopoulos, ... Journal of Medicinal Chemistry 59 (6), 2780-2793, 2016 | 55 | 2016 |
| HT‐SPOTi: a rapid drug susceptibility test (DST) to evaluate antibiotic resistance profiles and novel chemicals for anti‐infective drug discovery CA Danquah, A Maitra, S Gibbons, J Faull, S Bhakta Current protocols in microbiology 40 (1), 17.8. 1-17.8. 12, 2016 | 42 | 2016 |
| ProTides of N-(3-(5-(2′-deoxyuridine)) prop-2-ynyl) octanamide as potential anti-tubercular and anti-viral agents C McGuigan, M Derudas, B Gonczy, K Hinsinger, S Kandil, F Pertusati, ... Bioorganic & Medicinal Chemistry 22 (9), 2816-2824, 2014 | 41 | 2014 |
| Synthesis and SAR evaluation of novel thioridazine derivatives active against drug-resistant tuberculosis N Scalacci, AK Brown, FR Pavan, CM Ribeiro, F Manetti, S Bhakta, ... European journal of medicinal chemistry 127, 147-158, 2017 | 33 | 2017 |
| Novel anti-tuberculosis nanodelivery formulation of ethambutol with graphene oxide B Saifullah, A Chrzastek, A Maitra, B Naeemullah, S Fakurazi, S Bhakta, ... Molecules 22 (10), 1560, 2017 | 31 | 2017 |
| The draft genome of Mycobacterium aurum, a potential model organism for investigating drugs against Mycobacterium tuberculosis and Mycobacterium leprae J Phelan, A Maitra, R McNerney, M Nair, A Gupta, F Coll, A Pain, S Bhakta, ... International journal of mycobacteriology 4 (3), 207-216, 2015 | 31 | 2015 |
| Tetrahydroisoquinolines affect the whole-cell phenotype of Mycobacterium tuberculosis by inhibiting the ATP-dependent MurE ligase JD Guzman, T Pesnot, DA Barrera, HM Davies, E McMahon, ... Journal of Antimicrobial Chemotherapy 70 (6), 1691-1703, 2015 | 31 | 2015 |
| Analogues of Disulfides from Allium stipitatum Demonstrate Potent Anti-tubercular Activities through Drug Efflux Pump and Biofilm Inhibition CA Danquah, E Kakagianni, P Khondkar, A Maitra, M Rahman, ... Scientific Reports 8 (1), 1150, 2018 | 27 | 2018 |
| Nano-formulation of ethambutol with multifunctional graphene oxide and magnetic nanoparticles retains its anti-tubercular activity with prospects of improving chemotherapeutic … B Saifullah, A Maitra, A Chrzastek, B Naeemullah, S Fakurazi, S Bhakta, ... Molecules 22 (10), 1697, 2017 | 22 | 2017 |
| TB Summit 2014: prevention, diagnosis, and treatment of tuberculosis—a meeting report of a Euroscicon conference A Maitra, S Bhakta Virulence 5 (5), 638-644, 2014 | 20 | 2014 |
| Carprofen elicits pleiotropic mechanisms of bactericidal action with the potential to reverse antimicrobial drug resistance in tuberculosis A Maitra, D Evangelopoulos, A Chrzastek, LT Martin, A Hanrath, ... Journal of Antimicrobial Chemotherapy 75 (11), 3194-3201, 2020 | 19 | 2020 |
| Early diagnosis and effective treatment regimens are the keys to tackle antimicrobial resistance in tuberculosis (TB): A report from Euroscicon's international TB Summit 2016 A Maitra, TK Kamil, M Shaik, CA Danquah, A Chrzastek, S Bhakta Virulence 8 (6), 1005-1024, 2017 | 15 | 2017 |
| Synthesis, anti-mycobacterial activity and DNA sequence-selectivity of a library of biaryl-motifs containing polyamides F Brucoli, JD Guzman, A Maitra, CH James, KR Fox, S Bhakta Bioorganic & Medicinal Chemistry 23 (13), 3705-3711, 2015 | 15 | 2015 |
| Characterisation of a putative AraC transcriptional regulator from Mycobacterium smegmatis D Evangelopoulos, A Gupta, NA Lack, A Maitra, AMC ten Bokum, ... Tuberculosis 94 (6), 664-671, 2014 | 15 | 2014 |
| Exploration of 5‐(5‐nitrothiophen‐2‐yl)‐4, 5‐dihydro‐1H‐pyrazoles as selective, multitargeted antimycobacterial agents N Agre, M Khambete, A Maitra, A Gupta, T Munshi, S Bhakta, M Degani Chemical Biology & Drug Design 95 (1), 192-199, 2020 | 12 | 2020 |
| Improving the drug development pipeline for mycobacteria: Modelling antibiotic exposure in the hollow fibre infection model A Maitra, P Solanki, Z Sadouki, TD McHugh, F Kloprogge Antibiotics 10 (12), 1515, 2021 | 10 | 2021 |
| Characterization of the MurT/GatD complex in Mycobacterium tuberculosis towards validating a novel anti-tubercular drug target A Maitra, S Nukala, R Dickman, LT Martin, T Munshi, A Gupta, ... JAC-antimicrobial Resistance 3 (1), dlab028, 2021 | 10 | 2021 |
